MedTrace Logo

Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS

NCT02010554 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-12-02

No results posted yet for this study

Summary

Between 15-20% of MS patients decide not to initiate disease modifying therapies after being diagnosed with MS. For this study, we will develop a telephone-based talk therapy intervention and then conduct a randomized controlled trial. Patients will be assigned to either 5 weekly 20 minute telephone sessions of psychotherapy or a brief education control condition. We hypothesize that patients undergoing phone therapy will be more likely to indicate they are interested in initiating disease modifying medications than patients given brief education and treatment as usual.

Conditions

  • Relapsing-remitting Multiple Sclerosis

Interventions

BEHAVIORAL

Brief Education

Give patients a pamphlet discussing pros and cons of disease modifying therapies

BEHAVIORAL

Motivational Interviewing-Cognitive Behavioral Therapy

A telephone based talk therapy discussing pros and cons of medication use in MS.

Sponsors & Collaborators

  • University of Missouri, Kansas City

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-03-31
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02010554 on ClinicalTrials.gov